UBS Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21M | Buy |
|
|||||
|
2025
Q1 | $602K | Sell |
|
|||||
|
2024
Q4 | $788K | Sell |
|
|||||
|
2024
Q3 | $794K | Buy |
|
|||||
|
2024
Q2 | $521K | Sell |
|
|||||
|
2024
Q1 | $3.88M | Buy |
|
|||||
|
2023
Q4 | $2.83M | Buy |
|
|||||
|
2023
Q3 | $1.1M | Sell |
|
|||||
|
2023
Q2 | $1.65M | Sell |
|
|||||
|
2023
Q1 | $1.31M | Sell |
|
|||||
|
2022
Q4 | $4.72M | Buy |
|
|||||
|
2022
Q3 | $1.16M | Buy |
|
|||||
|
2022
Q2 | $2K | Sell |
|
|||||
|
2022
Q1 | $2.42M | Buy |
|
|||||
|
2021
Q4 | $897K | Buy |
|
|||||
|
2021
Q3 | $155K | Buy |
|
|||||
|
2021
Q2 | $92K | Buy |
|